Canada markets closed

Acorda Therapeutics, Inc. (CDG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
8.420.00 (0.00%)
At close: 03:32PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 17.53M
Enterprise Value 160.15M
Trailing P/E 0.97
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.10
Price/Book (mrq)0.17
Enterprise Value/Revenue 1.44
Enterprise Value/EBITDA 3.63

Trading Information

Stock Price History

Beta (5Y Monthly) 1.73
52-Week Change 3-50.16%
S&P500 52-Week Change 323.49%
52 Week High 318.40
52 Week Low 37.64
50-Day Moving Average 38.42
200-Day Moving Average 38.75

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 51.24M
Implied Shares Outstanding 61.67M
Float 81.23M
% Held by Insiders 10.64%
% Held by Institutions 113.93%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jun 05, 2023

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -227.75%
Operating Margin (ttm)-65.98%

Management Effectiveness

Return on Assets (ttm)-6.59%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)115.66M
Revenue Per Share (ttm)93.13
Quarterly Revenue Growth (yoy)-8.80%
Gross Profit (ttm)N/A
EBITDA 551k
Net Income Avi to Common (ttm)-263.42M
Diluted EPS (ttm)8.70
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.36M
Total Cash Per Share (mrq)7.54
Total Debt (mrq)195.92M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.22
Book Value Per Share (mrq)-149.56

Cash Flow Statement

Operating Cash Flow (ttm)-27.15M
Levered Free Cash Flow (ttm)6.01M